Correlation Between Cybin and Antibe Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cybin and Antibe Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cybin and Antibe Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cybin Inc and Antibe Therapeutics, you can compare the effects of market volatilities on Cybin and Antibe Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cybin with a short position of Antibe Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cybin and Antibe Therapeutics.
Diversification Opportunities for Cybin and Antibe Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Cybin and Antibe is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cybin Inc and Antibe Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Antibe Therapeutics and Cybin is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cybin Inc are associated (or correlated) with Antibe Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Antibe Therapeutics has no effect on the direction of Cybin i.e., Cybin and Antibe Therapeutics go up and down completely randomly.
Pair Corralation between Cybin and Antibe Therapeutics
Given the investment horizon of 90 days Cybin Inc is expected to generate 0.88 times more return on investment than Antibe Therapeutics. However, Cybin Inc is 1.14 times less risky than Antibe Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Antibe Therapeutics is currently generating about 0.02 per unit of risk. If you would invest 1,231 in Cybin Inc on August 29, 2024 and sell it today you would lose (160.00) from holding Cybin Inc or give up 13.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cybin Inc vs. Antibe Therapeutics
Performance |
| Timeline |
| Cybin Inc |
| Antibe Therapeutics |
Cybin and Antibe Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cybin and Antibe Therapeutics
The main advantage of trading using opposite Cybin and Antibe Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cybin position performs unexpectedly, Antibe Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Antibe Therapeutics will offset losses from the drop in Antibe Therapeutics' long position.| Cybin vs. Mind Medicine | Cybin vs. Seelos Therapeutics | Cybin vs. GH Research PLC | Cybin vs. Awakn Life Sciences |
| Antibe Therapeutics vs. Rezolute | Antibe Therapeutics vs. Tempest Therapeutics | Antibe Therapeutics vs. Forte Biosciences | Antibe Therapeutics vs. Dyadic International |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |